Respiratory Viral and Bacterial Superinfection
Nima Naghshtabrizi1, Keven M Robinson1
1Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, 3459 Fifth Avenue, 628 Northwest, Pittsburgh, PA 15213, USA.
Clinics in Chest Medicine
|May 27, 2026
Summary
Respiratory viral infections pave the way for secondary bacterial pneumonia, increasing disease severity and mortality. This review details how viruses compromise lung defenses, creating opportunities for bacterial superinfections.
Area of Science:
- Pulmonology and Infectious Diseases
- Immunology
- Microbiology
Background:
- Respiratory viral infections frequently precede bacterial pneumonia, a serious complication.
- Bacterial pneumonia following viral infection leads to worse outcomes, longer hospital stays, and increased death rates.
- Understanding the interplay between viral and bacterial pathogens is crucial for clinical management.
Purpose of the Study:
- To review the mechanisms by which respiratory viruses facilitate secondary bacterial pneumonia.
- To highlight common pathogenic processes across various respiratory viruses.
- To provide a comprehensive understanding of viral-induced host susceptibility to bacterial superinfection.
Main Methods:
- Literature review of existing studies on viral-bacterial interactions in the respiratory tract.
- Analysis of pathogenic mechanisms involving lung physiology, immune defenses, and cytokine signaling.
- Synthesis of information on commonalities in viral-induced susceptibility.
Main Results:
- Viral infections disrupt lung structure and function.
- Viruses impair both innate and adaptive immune responses, weakening host defenses.
- Dysregulated cytokine signaling creates an environment favorable for bacterial growth.
Conclusions:
- Respiratory viruses significantly increase the risk of secondary bacterial pneumonia.
- Viruses alter host defenses, making the lungs more vulnerable to bacterial invasion.
- A comprehensive understanding of these mechanisms is essential for developing preventative and therapeutic strategies.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Related Concept Videos
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...